Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker
Authors
Keywords
Circulate Tumor Cell, National Comprehensive Cancer Network, Metastatic Breast Cancer Patient, CellSearch System, Circulate Tumor Cell Detection
Journal
BMC CANCER
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-04-24
DOI
10.1186/1471-2407-13-202
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapy
- (2011) A. Giordano et al. ANNALS OF ONCOLOGY
- Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors
- (2011) Naoki Niikura et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast Cancer Management: Opportunities and Barriers to an Individualized Approach
- (2011) E. A. Perez ONCOLOGIST
- HER2-Positive Circulating Tumor Cells in Breast Cancer
- (2011) Michail Ignatiadis et al. PLoS One
- Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization
- (2010) A. Gradilone et al. ANNALS OF ONCOLOGY
- HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial
- (2010) Tanja Fehm et al. BREAST CANCER RESEARCH AND TREATMENT
- Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer
- (2010) L M Flores et al. BRITISH JOURNAL OF CANCER
- Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial
- (2010) S. Riethdorf et al. CLINICAL CANCER RESEARCH
- Circulating tumour cells in clinical practice: Methods of detection and possible characterization
- (2010) Marianna Alunni-Fabbroni et al. METHODS
- Estrogen and HER-2 Receptor Discordance Between Primary Breast Cancer and Metastasis
- (2010) L. Pusztai et al. ONCOLOGIST
- Molecular Biomarker Analyses Using Circulating Tumor Cells
- (2010) Elizabeth A. Punnoose et al. PLoS One
- Circulating tumour cells in cancer patients: challenges and perspectives
- (2010) Klaus Pantel et al. TRENDS IN MOLECULAR MEDICINE
- Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients
- (2009) Marta Pestrin et al. BREAST CANCER RESEARCH AND TREATMENT
- Circulating Tumor Cells and [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Outcome Prediction in Metastatic Breast Cancer
- (2009) Ugo De Giorgi et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies
- (2008) Mitra Tewes et al. BREAST CANCER RESEARCH AND TREATMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation